These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 12269791)

  • 1. Increases in myocardial cyclic GMP attenuate contractile delay in myocardial stunning.
    Huang MW; Scholz PM; Weiss HR
    Can J Physiol Pharmacol; 2002 Aug; 80(8):804-10. PubMed ID: 12269791
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reduction in the level of cardiac cyclic GMP worsens contractile delay in myocardial stunning.
    Patel KN; Weiss HR; Scholz PM
    J Surg Res; 2000 Jul; 92(1):114-9. PubMed ID: 10864491
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Atrial natriuretic peptide reverses the negative functional effects of stunning in rabbit myocardium.
    Moalem J; Davidov T; Katz E; Scholz PM; Weiss HR
    Regul Pept; 2005 Dec; 132(1-3):47-52. PubMed ID: 16223535
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Brain natriuretic peptide reverses the effects of myocardial stunning in rabbit myocardium.
    Anyadike C; Scholz PM; Zhang Q; Katz E; Weiss HR
    Pharmacology; 2007; 80(1):40-8. PubMed ID: 17519532
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cyclic GMP reduces myocardial stunning through non-cyclic GMP protein kinase mechanisms.
    Zhang Q; Lazar M; Yan L; He Y; Tse J; Weiss HR; Scholz PM
    J Cardiovasc Pharmacol; 2004 Aug; 44(2):235-43. PubMed ID: 15243306
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cyclic GMP reduces ventricular myocyte stunning after simulated ischemia-reperfusion.
    Gandhi A; Yan L; Scholz PM; Huang MW; Weiss HR
    Nitric Oxide; 1999 Dec; 3(6):473-80. PubMed ID: 10637126
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Local inotropic stimulation by methylene blue does not improve mechanical dysfunction due to myocardial stunning.
    Naim KL; Weiss HR; Guo X; Sadoff J; Scholz P; Kedem J
    Res Exp Med (Berl); 1997; 197(1):23-35. PubMed ID: 9226760
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reduced myocardial cyclic GMP increases myocardial O2 consumption in control but not renal hypertension-induced cardiac hypertrophy.
    Sadoff JD; Scholz PM; Tse J; Weiss HR
    Cardiovasc Res; 1997 Dec; 36(3):453-9. PubMed ID: 9534866
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acetaminophen and myocardial stunning after transient ischemia in rabbit hearts.
    Hale SL; Kloner RA
    J Cardiovasc Pharmacol Ther; 2005 Jun; 10(2):121-9. PubMed ID: 15965563
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ageing blunts the effects of nitric oxide on myocardial O2 consumption.
    Weiss HR; Lazar MJ; Tse J; Scholz PM
    Clin Exp Pharmacol Physiol; 2002 Oct; 29(10):924-30. PubMed ID: 12207573
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cyclic GMP attenuates cyclic AMP-stimulated inotropy and oxygen consumption in control and hypertrophic hearts.
    Leone RJ; Straznicka M; Scholz PM; Weiss HR
    Basic Res Cardiol; 2000 Feb; 95(1):28-38. PubMed ID: 10752543
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Altered relationship between cyclic GMP and myocardial O2 consumption in renal hypertension-induced cardiac hypertrophy.
    Rabindranauth P; Scholz PM; Tse J; Naim KL; Weiss HR
    Res Exp Med (Berl); 1998 Jul; 198(1):11-21. PubMed ID: 9706666
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Negative metabolic effects of cyclic GMP are altered in renal hypertension induced cardiac hypertrophy.
    Rabindranauth P; Naim KL; Scholz PM; Tse J; Sadoff JD; Weiss HR
    Basic Res Cardiol; 1997 Feb; 92(1):8-16. PubMed ID: 9062647
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ethanol-induced reduction in myocardial oxygen consumption can be attenuated by inhibiting guanylyl cyclase.
    Lazar MJ; Patel K; Scholz PM; Weiss HR
    J Cardiovasc Pharmacol; 2001 Oct; 38(4):512-9. PubMed ID: 11588521
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nitroprusside reverses lengthened time of contraction in stunned canine cardiac myocytes.
    Straznicka M; Scholz PM; Gong G; Weiss HR
    J Cardiovasc Pharmacol; 2000 Feb; 35(2):219-26. PubMed ID: 10672853
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of verapamil on myocardial stunning in xanthine-oxidase deficient hearts: pre-treatment vs. post-ischemic treatment.
    Adachi T; Miura T; Suzuki K; Iimura O
    Basic Res Cardiol; 1994; 89(1):16-28. PubMed ID: 8010931
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regional asynchrony of segmental contraction may explain the "oxygen consumption paradox" in stunned myocardium.
    Chiu WC; Kedem J; Scholz PM; Weiss HR
    Basic Res Cardiol; 1994; 89(2):149-62. PubMed ID: 8074639
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nitroprusside attenuates myocardial stunning through reduced contractile delay and time.
    Leone RJ; Scholz PM; Weiss HR
    Proc Soc Exp Biol Med; 2000 Mar; 223(3):263-9. PubMed ID: 10719838
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Haemodynamic and energetic properties of stunned myocardium in rabbit hearts.
    Schipke JD; Korbmacher B; Dorszewski A; Selcan G; Sunderdiek U; Arnold G
    Heart; 1996 Jan; 75(1):55-61. PubMed ID: 8624873
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Negative metabolic and coronary flow effects of decreases in cAMP and increases in cGMP in control and renal hypertensive rabbit hearts.
    Rodriguez R; Molino B; Weiss HR; Scholz PM
    J Appl Physiol (1985); 2004 Jul; 97(1):439-45. PubMed ID: 14990553
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.